LeMaitre Vascular Book Value 2011-2026 | LMAT

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.

What is included in book value

Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.

Features of the metric

Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value LeMaitre Vascular

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
394 M	337 M	298 M	268 M	254 M	173 M	148 M	130 M	110 M	87.5 M	77.9 M	68.2 M	56.6 M	52.9 M	52.1 M	52.4 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
394 M	52.1 M	160 M

Quarterly Book Value LeMaitre Vascular

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
407 M	379 M	363 M	348 M	331 M	320 M	-	289 M	284 M	274 M	268 M	261 M	-	258 M	254 M	249 M	186 M	178 M	173 M	173 M	173 M	173 M	148 M	148 M	148 M	148 M	130 M	130 M	130 M	130 M	110 M	110 M	110 M	110 M	87.5 M	87.5 M	87.5 M	87.5 M	77.9 M	77.9 M	77.9 M	77.9 M	68.2 M	68.2 M	68.2 M	68.2 M	56.6 M	56.6 M	56.6 M	56.6 M	52.9 M	52.9 M	52.9 M	52.9 M	52.1 M	52.1 M	52.1 M	52.1 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
407 M	52.1 M	151 M

Book Value of other stocks in the Medical instruments industry

Issuer	Book Value	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	243 K	-	-	$ 810 M	USA
The Cooper Companies COO	8.24 B	$ 61.75	0.49 %	$ 12.3 B	USA
Luminex Corporation LMNX	199 M	-	-	$ 1.75 B	USA
Akers Biosciences, Inc. AKER	76.5 M	-	-9.52 %	$ 20.6 M	USA
ICU Medical ICUI	4.05 B	$ 129.31	4.57 %	$ 3.19 B	USA
Alcon ALC	22 B	$ 67.28	1.48 %	$ 40.4 B	Schweiz
Intuitive Surgical ISRG	17.9 B	$ 449.03	1.69 %	$ 160 B	USA
iRhythm Technologies IRTC	153 M	$ 117.0	2.78 %	$ 3.74 B	USA
Repro Med Systems KRMD	17 M	$ 4.0	1.01 %	$ 185 M	USA
Antares Pharma, Inc. ATRS	257 M	-	-	$ 955 M	USA
Cantel Medical Corp. CMD	411 M	-	-1.18 %	$ 3.4 B	USA
CRH Medical Corporation CRHM	762 M	-	-	$ 282 M	USA
Hill-Rom Holdings, Inc. HRC	388 M	-	-0.05 %	$ 10.3 B	USA
Masimo Corporation MASI	1.05 B	$ 178.79	-0.01 %	$ 9.53 B	USA
Milestone Scientific MLSS	2.81 M	$ 0.4	14.99 %	$ 32.8 M	USA
Ekso Bionics Holdings EKSO	9.03 M	-	-	$ 28.6 M	USA
Varian Medical Systems, Inc. VAR	66.7 M	-	-0.02 %	$ 16.3 B	USA
electroCore ECOR	-1.71 M	$ 6.13	3.81 %	$ 52 K	USA
Envista Holdings Corporation NVST	5.68 B	$ 23.77	3.15 %	$ 3.99 B	USA
Haemonetics Corporation HAE	2.45 B	$ 59.56	4.79 %	$ 3 B	USA
STERIS plc STE	6.62 B	$ 215.97	0.67 %	$ 21.3 B	USA
Isoray ISR	207 M	-	0.03 %	$ 108 M	USA
Glaukos Corporation GKOS	462 M	$ 143.82	2.71 %	$ 6.97 B	USA
STAAR Surgical Company STAA	344 M	$ 33.05	1.38 %	$ 1.64 B	USA
InfuSystem Holdings INFU	57.3 M	$ 10.16	5.07 %	$ 210 M	USA
Microbot Medical MBOT	77.6 M	$ 1.74	0.58 %	$ 79.7 M	Israel
Teleflex Incorporated TFX	3.12 B	$ 135.18	1.81 %	$ 6.03 B	USA
Utah Medical Products UTMD	119 M	$ 64.17	0.27 %	$ 208 M	USA
Merit Medical Systems MMSI	1.58 B	$ 64.49	1.13 %	$ 3.82 B	USA
West Pharmaceutical Services WST	3.18 B	$ 305.5	0.55 %	$ 22.1 B	USA
DENTSPLY SIRONA XRAY	1.34 B	$ 9.84	1.03 %	$ 1.96 B	USA
Pulse Biosciences PLSE	80.7 M	$ 26.09	4.57 %	$ 1.76 B	USA
Retractable Technologies RVP	74.4 M	$ 0.66	-2.35 %	$ 19.8 M	USA
Pro-Dex PDEX	36.6 M	$ 63.47	4.43 %	$ 209 M	USA
Predictive Oncology POAI	47.7 M	-	-	$ 31.1 M	USA
BioLife Solutions BLFS	372 M	$ 24.0	4.12 %	$ 1.15 B	USA
Stereotaxis STXS	18.7 M	$ 1.85	7.56 %	$ 168 M	USA
Baxter International BAX	6.1 B	$ 18.77	2.37 %	$ 9.63 B	USA
ResMed RMD	3.36 B	$ 209.86	0.98 %	$ 30.7 B	USA
AtriCure ATRC	492 M	$ 29.0	0.69 %	$ 1.38 B	USA
Harvard Bioscience HBIO	13.7 M	$ 5.4	7.78 %	$ 240 M	USA
NeuroMetrix NURO	14.3 M	-	5.05 %	$ 9.02 M	USA
AngioDynamics ANGO	183 M	$ 11.81	3.23 %	$ 482 M	USA
Becton, Dickinson and Company BDX	55.3 B	$ 146.95	0.02 %	$ 42.3 B	USA
Nephros NEPH	10.2 M	$ 3.57	-1.79 %	$ 37.9 M	USA
OraSure Technologies OSUR	341 M	$ 3.07	-0.32 %	$ 226 M	USA
Repligen Corporation RGEN	2.11 B	$ 111.74	2.97 %	$ 6.28 M	USA